Robert W. Hesslein, Senior VP & General Counsel at Voyager Therapeutics, Inc. (VYGR), sold 3,091 shares at $8.51 ($26K) on 2020-04-03, disclosed to the SEC on 2020-04-07.
Scheduled sale ($26k) by Senior VP & General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| Filing → |
| VYGR | SELL | 2023-02-15 | $22K | — | Filing → |
| VYGR | SELL | 2023-01-19 | $22K | — | Filing → |
| VYGR | SELL | 2022-04-06 | $23K | — | Filing → |